Jim Chanos shares his views on investing in an exclusive interview for CNBC PRO with Mike Santoli. » Read More
By: Alexander Nazaryan
Jimmy Kimmel once again devoted the monologue of his show to an extraordinary rant against the GOP health-care bill, Newsweek reports. » Read More
By: Dylan Scott
Republican senators' health care bill could be a few votes from passing, Vox reports. » Read More
By: Glenn W. Simon
Drug companies contributed to the opioid crisis, but so did lots of other stakeholders, says Glenn W. Simon in National Review. » Read More
A new beauty routine that involves having your face pummeled is taking on a global cosmetics industry that provides nearly 5 million Botox injections every year.
Graham called the "Obamacare" repeal bill he co-authored a "historic opportunity" and asserted: "We're going to vote. Everyone will be held accountable."
Collaborative relationships with hospitals across the globe are improving patient outcomes and operational efficiencies.
A slew of patient and provider groups, as well as the AARP, oppose the last-ditch repeal bill.
An analyst report states that Amazon is starting to meet with pharmacy benefits managers.
Obama's comment came as the Graham-Cassidy Obamacare repeal plan is gaining traction in the Senate.
Congress has a Sept. 30 deadline to pass an Obamacare repeal bill.
While other GOP health bills essentially create a poorly funded version of the Affordable Care Act, Graham-Cassidy blows it up, says Vox's Sarah Kliff.
Martin Shkreli's bail was revoked last week by a judge for having offered Facebook followers $5,000 for samples of Hillary Clinton's hair.
Republican senators are struggling to articulate why they are rushing to pass their Obamacare repeal plan, Vox reports.
The Graham-Cassidy bill would end Obamacare's expansion of Medicaid benefits and subsidies for private insurance plans.
The GOP Obamacare repeal bill would achieve political goals, but on policy, here's where it falls short, says Consultant Robert Laszewski.
HHS Secretary Tom Price reportedly took five private jets for official business last week.
Pfizer filed a lawsuit against Johnson & Johnson, saying their anticompetitive contracts with health insurers prevented biosimilar competition to Remicade.
Companies that make lab equipment, testing supplies and analytical devices have driven the sector up 41 percent, beating the much-discussed internet giants
Goldman Sachs lowers its rating for Johnson & Johnson to sell from neutral.
Get the best of CNBC in your inbox